Abundance of viral gastroenteritis before and after the emergence of COVID-19: Molecular evidence on wastewater - 28/01/23
Doi : 10.1016/j.jinf.2022.11.007
Sheikh Ariful Hoque a, b, Tomohiro Kotaki c, Ngan Thi Kim Pham a, Yuko Onda a, Shoko Okitsu a, Shintaro Sato c, d, Yoshikazu Yuki e, Takeshi Kobayashi c, Niwat Maneekarn f, Hiroshi Kiyono e, g, h, Satoshi Hayakawa a, Hiroshi Ushijima a, ⁎ 
a Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo 173-0032, Japan
b Cell and Tissue Culture Laboratory, Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka 1000, Bangladesh
c Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
d Department of Microbiology and Immunology, School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama 640-8156, Japan
e Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan
f Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
g Research Institute of Disaster Medicine, Institute for Advanced Academic Research, Institute for Global Prominent Research, Chiba University, Chiba, Japan
h CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, USA
⁎Corresponding author at: Nihon University School of Medicine, 30-1 OyaguchiKamicho, Itabashi-ku, Tokyo 173-8610, Japan.Nihon University School of Medicine, 30-1 OyaguchiKamicho, Itabashi-kuTokyo173-8610Japan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2022
Publié par Elsevier Masson SAS.
Vol 86 - N° 2
P. 154-225 - février 2023 Retour au numéro
Article précédent
- Safety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trial
- Guiqiang Wang, Kexin Zhao, Jun Han, Zhongyu Hu, Tianzuo Zhang, Yanchao Wang, Rui Shi, Yanhua Li, Qinqin Song, Haijun Du, Peng He, Shuping Xu, Xinjie Yang, Yongpan Fu, Yimin Cui, Liangzhi Xie
- Changes in pathogen distribution in the blood culture of neonates before and after the COVID-19 pandemic, Henan, China
- Tiewei Li, Xiaojuan Li, Kaijie Gao, Geng Dong, Junmei Yang
Bienvenue sur EM-consulte, la référence des professionnels de santé.